Professor McDougall’s research focuses on the neurobiology of pain and inflammation in the development of arthritis. His research currently examines the role of cannabinoids and proteinases in the control of arthritis pain and inflammation. His research goal is to identify novel drug targets and develop new treatments that will help alleviate chronic pain and resolve joint inflammation. He currently receives project funding from CIHR and The Arthritis Society. He has been a consultant for AstraZeneca (UK), Eli Lilly & Company (USA), Pfizer (UK), Pharmin (USA) and Antibe Pharmaceuticals (Canada). Prof. McDougall is an editor for Inflammation Research, the Journal of Inflammation, and BMC Anaesthesiology. He is currently the President Elect of the International Association of Inflammation Societies and President of the Inflammation Research Network of Canada. He has also won numerous awards for his homebrewed beers which have been commercially produced.